(ULTA) Ulta Beauty - Ratings and Ratios
Cosmetics, Skincare, Fragrance, Haircare, Beauty Tools
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 33.9% |
| Value at Risk 5%th | 47.0% |
| Relative Tail Risk | -15.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 25.75 |
| CAGR/Max DD | 0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.333 |
| Beta | 0.877 |
| Beta Downside | 0.638 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.56% |
| Mean DD | 19.40% |
| Median DD | 20.19% |
Description: ULTA Ulta Beauty December 17, 2025
Ulta Beauty, Inc. (NASDAQ:ULTA) is a U.S.-based specialty beauty retailer operating stores, shop-in-shops, an e-commerce platform, and mobile apps across the United States, Mexico, and Kuwait. The company sells a mix of branded and private-label cosmetics, fragrance, hair-care, skin-care, bath-and-body, professional hair products, and salon styling tools, while also offering in-store services such as hair, makeup, brow, and skin treatments.
Key recent metrics: for FY 2024, Ulta reported comparable-store sales growth of 8.2% and a 12-month trailing gross margin of ~38%, reflecting strong demand for premium beauty products and services. The “beauty-as-a-service” model-driven by higher-margin salon offerings-contributes roughly 30% of total revenue, cushioning the business against pure product-price pressure. Macro-level, consumer discretionary spending remains sensitive to disposable-income trends and inflation, but the sector benefits from a long-term shift toward “self-care” and “look-good-feel-good” spending patterns.
For a deeper, data-driven view of Ulta’s valuation and risk profile, you might explore the analyst tools on ValueRay to see how these drivers stack up against peers.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1.19b TTM) > 0 and > 6% of Revenue (6% = 718.9m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA -1.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.95% (prev 10.02%; Δ -3.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 1.36b > Net Income 1.19b (YES >=105%, WARN >=100%) |
| Net Debt (2.37b) to EBITDA (1.87b) ratio: 1.27 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.9m) change vs 12m ago -4.67% (target <= -2.0% for YES) |
| Gross Margin 39.19% (prev 38.67%; Δ 0.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 184.8% (prev 190.7%; Δ -5.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 383.1 (EBITDA TTM 1.87b / Interest Expense TTM 4.12m) >= 6 (WARN >= 3) |
Altman Z'' 3.53
| (A) 0.12 = (Total Current Assets 3.37b - Total Current Liabilities 2.54b) / Total Assets 7.01b |
| (B) 0.22 = Retained Earnings (Balance) 1.58b / Total Assets 7.01b |
| (C) 0.24 = EBIT TTM 1.58b / Avg Total Assets 6.49b |
| (D) 0.36 = Book Value of Equity 1.58b / Total Liabilities 4.38b |
| Total Rating: 3.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.18
| 1. Piotroski 7.50pt |
| 2. FCF Yield 3.57% |
| 3. FCF Margin 8.69% |
| 4. Debt/Equity 0.98 |
| 5. Debt/Ebitda 1.27 |
| 6. ROIC - WACC (= 35.98)% |
| 7. RoE 46.87% |
| 8. Rev. Trend 40.51% |
| 9. EPS Trend 5.57% |
What is the price of ULTA shares?
Over the past week, the price has changed by +1.61%, over one month by +13.52%, over three months by +10.06% and over the past year by +36.15%.
Is ULTA a buy, sell or hold?
- Strong Buy: 9
- Buy: 4
- Hold: 13
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the ULTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 618.2 | 1.8% |
| Analysts Target Price | 618.2 | 1.8% |
| ValueRay Target Price | 668.2 | 10% |
ULTA Fundamental Data Overview December 23, 2025
P/E Trailing = 22.9336
P/E Forward = 21.322
P/S = 2.2373
P/B = 10.0733
P/EG = 2.413
Beta = 0.866
Revenue TTM = 11.98b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 1.87b USD
Long Term Debt = 2.02b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 842.4m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 29.18b USD (26.81b + Debt 2.57b - CCE 204.9m)
Interest Coverage Ratio = 383.1 (Ebit TTM 1.58b / Interest Expense TTM 4.12m)
FCF Yield = 3.57% (FCF TTM 1.04b / Enterprise Value 29.18b)
FCF Margin = 8.69% (FCF TTM 1.04b / Revenue TTM 11.98b)
Net Margin = 9.93% (Net Income TTM 1.19b / Revenue TTM 11.98b)
Gross Margin = 39.19% ((Revenue TTM 11.98b - Cost of Revenue TTM 7.29b) / Revenue TTM)
Gross Margin QoQ = 40.44% (prev 39.15%)
Tobins Q-Ratio = 4.16 (Enterprise Value 29.18b / Total Assets 7.01b)
Interest Expense / Debt = 0.16% (Interest Expense 4.12m / Debt 2.57b)
Taxrate = 24.13% (73.4m / 304.3m)
NOPAT = 1.20b (EBIT 1.58b * (1 - 24.13%))
Current Ratio = 1.33 (Total Current Assets 3.37b / Total Current Liabilities 2.54b)
Debt / Equity = 0.98 (Debt 2.57b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.27 (Net Debt 2.37b / EBITDA 1.87b)
Debt / FCF = 2.28 (Net Debt 2.37b / FCF TTM 1.04b)
Total Stockholder Equity = 2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.97% (Net Income 1.19b / Total Assets 7.01b)
RoE = 46.87% (Net Income TTM 1.19b / Total Stockholder Equity 2.54b)
RoCE = 34.62% (EBIT 1.58b / Capital Employed (Equity 2.54b + L.T.Debt 2.02b))
RoIC = 44.43% (NOPAT 1.20b / Invested Capital 2.70b)
WACC = 8.45% (E(26.81b)/V(29.38b) * Re(9.25%) + D(2.57b)/V(29.38b) * Rd(0.16%) * (1-Tc(0.24)))
Discount Rate = 9.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.50%
[DCF Debug] Terminal Value 74.27% ; FCFE base≈1.02b ; Y1≈1.04b ; Y5≈1.14b
Fair Price DCF = 366.2 (DCF Value 16.25b / Shares Outstanding 44.4m; 5y FCF grow 1.36% → 3.0% )
EPS Correlation: 5.57 | EPS CAGR: -1.36% | SUE: 1.12 | # QB: 5
Revenue Correlation: 40.51 | Revenue CAGR: 1.23% | SUE: 3.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=7.24 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=15
EPS next Year (2027-01-31): EPS=28.31 | Chg30d=+1.311 | Revisions Net=+18 | Growth EPS=+10.8% | Growth Revenue=+5.6%
Additional Sources for ULTA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle